VaccineHumansMassachusettsCOVID-19FemaleMale
Population-based serosurveys for SARS-CoV-2 transmission 2021-2022, Massachusetts USA.
Estee Y Cramer, Augustine O Dada, Shauna Onofrey, Jessica Pearlman, John Cluverius, Rebecca Loveland, Ashley Eaton, Megan Hatch, Lily Harris, Joshua J Dyck, Mark Melnik, Peter Reinhart, Andrew A Lover, Monina R Klevens
Published: 202610.1016/j.vaccine.2025.127952
Abstract
BACKGROUND: SARS-CoV-2 has been responsible for extensive morbidity and mortality in Massachusetts, especially during the 2021-2022 time period. The true burden of infection is unknown as official reporting data during 2021 and 2022 was not able to c…
Preview only. Read the full abstract at the source